|
|
||||||||
, and Various Inhibitors of TCR Signaling1
* Division of Immunogenetics, Tumorimmunology Program, German Cancer Research Center, Heidelberg, Germany; and
Immunomonitoring Unit, National Center for Tumor Diseases and Institute for Immunology, Heidelberg, Germany
CD4+CD25high forkhead box P3+ regulatory T cells (Treg) are critical mediators of peripheral self-tolerance and immune homeostasis. Treg suppress proliferation and cytokine production of conventional T cells (Tcon). The exact mechanism of suppression, however, is still unknown. To gain a better understanding of Treg function, we investigated the kinetics of cytokine suppression in Tcon reisolated from cocultures with preactivated human Treg. Treg inhibited induction of Th1 cytokine mRNA as early as 1 h after stimulation, whereas induction/suppression of Th2 cytokines was delayed to 10–15 h. We show that immediate cytokine mRNA suppression in Tcon was neither dependent on TGF-
/IL-10 or IL-2 consumption, nor on induction of the transcriptional-repressor forkhead box P3 or other anergy-related genes (e.g., gene related to anergy, transducer of ErbB-2, forkhead homolog-4, repressor of GATA, inducible cAMP early repressor). In contrast, lymphocyte activation gene 3, suppressor of cytokine signaling 1, and suppressor of cytokine signaling 3 mRNA were strongly up-regulated in Tcon in the presence of Treg. However, protein analysis did not confirm a role for these proteins in early suppression. Thus, the identification of a fast inhibitory mechanism in Tcon induced by Treg constitutes an important step for future efforts to unravel the entire elusive suppressive mechanism.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a grant from the "Landesstiftung Baden-Württemberg" Germany (P-LS-AL/13) to E.S.-P. and SFB 405 to P.H.K.
2 Address correspondence and reprint requests to Dr. Nina Oberle, Division of Immunogenetics (D030), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg. E-mail address: N.Oberle{at}dkfz.de
3 Abbreviations used in this paper: FOXP3, forkhead box P3; FOXJ1, forkhead homolog-4; GRAIL, gene related to anergy; ICER, inducible cAMP early repressor; LAG-3, lymphocyte activation gene 3; LKLF, lung Krüppel-like factor; rh, recombinant human; ROG, repressor of GATA; SOCS, suppressor of cytokine signaling; Tcon, conventional T cell; TOB, transducer of ErbB-2; Treg, regulatory T cell.
This article has been cited by other articles:
![]() |
Q. Chen, T. S. Davidson, E. N. Huter, and E. M. Shevach Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival J. Immunol., October 1, 2009; 183(7): 4458 - 4466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Ahmed, N. Belhadj Hmida, N. Moes, S. Buyse, M. Abdeladhim, H. Louzir, and N. Cerf-Bensussan IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway J. Immunol., June 1, 2009; 182(11): 6763 - 6770. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wang, G.-H. Chen, Y. Fan, M. Van Antwerp, and J. R. Baker Jr. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis by the Expansion of CD4+CD25+ Regulatory T Cells Endocrinology, April 1, 2009; 150(4): 2000 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Q. Tran, D. D. Glass, G. Uzel, D. A. Darnell, C. Spalding, S. M. Holland, and E. M. Shevach Analysis of Adhesion Molecules, Target Cells, and Role of IL-2 in Human FOXP3+ Regulatory T Cell Suppressor Function J. Immunol., March 1, 2009; 182(5): 2929 - 2938. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inaba, M. Steeves, P. Nguyen, and T. L. Geiger In Vivo Suppression of Naive CD4 T Cell Responses by IL-2- and Antigen-Stimulated T Lymphocytes in the Absence of APC Competition J. Immunol., September 1, 2008; 181(5): 3323 - 3335. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |